Directorate Change

RNS Number : 1938D
Immupharma PLC
23 October 2015
 

 

FOR IMMEDIATE RELEASE

23 OCTOBER 2015

 

 

BOARD CHANGE

 

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that Ajay Agrawal has stepped down as Non-Executive Director with immediate effect.

 

Tim McCarthy, Non-Executive Chairman said: "We would like to thank Ajay for his contribution whilst at ImmuPharma.

 

"In the short period of time as Chairman, I have become more convinced of our lead programme Lupuzor. This has the potential to bring success for ImmuPharma, reward our long standing shareholders and ultimately to provide a significant treatment for lupus sufferers, globally. I am delighted to be part of the team driving this strategy forward."

 

-Ends-

 

 

For further information please contact:

 

ImmuPharma plc

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman


Lisa Baderoon, Head of Investor Relations

+ 44 (0) 7721 413496



Panmure, Gordon & Co., NOMAD & Broker

+44 (0) 20 7886 2500

Fred Walsh, Duncan Monteith, Corporate Finance

Charles Leigh-Pemberton, Corporate Broking

 










 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPKBDQNBDBAKB

Companies

Immupharma (IMM)
UK 100

Latest directors dealings